Levodopa/carbidopa: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Levodopa/carbidopa

• Fexofenadine as Adjuvant Therapy in Parkinson Disease
  NCT06785298 · Phase: Phase 2, Phase 3 · Ages: 50 Years to 70 Years · Sex: All (male and female) · 1 location
• Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
  NCT07001150 · Phase: Phase 2 · Ages: 45 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Levodopa/carbidopa?

2 recruiting trials across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.